165 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B N/A
Article Searches
3 Big Pharma Companies With the Best Projected Return on Investment https://www.fool.com/investing/2017/07/19/3-big-pharma-companies-with-the-best-projected-ret.aspx?source=iedfolrf0000001 Jul 19, 2017 - Novo Nordisk, Celgene, and Bayer should get the biggest bang for the buck on their R&D and acquisitions.
Stocks making the biggest moves premarket: DKS, TGT, CRM, HPQ, NVO, KORS & more https://www.cnbc.com/2018/05/30/stocks-making-the-biggest-moves-premarket-dks-tgt-crm-hpq-nvo-kors-more.html May 30, 2018 - Names on the move ahead of the open.
High-Yield Healthcare Investments You Can Buy Right Now https://www.fool.com/investing/2017/04/18/high-yield-healthcare-investments-you-can-buy-righ.aspx?source=iedfolrf0000001 Apr 18, 2017 - Want high dividend yields? Check out healthcare stocks AbbVie, Pfizer, and Novo Nordisk.
3 Beaten-Up Healthcare Stocks: Are They Bargains? https://www.fool.com/investing/2017/04/19/3-beaten-up-healthcare-stocks-are-they-bargains.aspx?source=iedfolrf0000001 Apr 19, 2017 - The past year hasn't been kind to shareholders of Alexion Pharmaceuticals, Opko Health, and Novo Nordisk. Do their stocks hold value today, or should they be avoided?
Big Pharma Diabetes Drugs Not So Sweet. What's in Store? http://www.zacks.com/stock/news/262544/big-pharma-diabetes-drugs-not-so-sweet-whats-in-store?cid=CS-ZC-FT-262544 May 31, 2017 - Aales of diabetes drugs from most large pharma companies slipped in the first quarter.
Is Novo Nordisk (NVO) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat http://www.zacks.com/stock/news/188252/novo-nordisk-may-be-an-impressive-growth-pick-right-now?cid=CS-ZC-FT-188252 Aug 31, 2015 - Novo Nordisk stock is a potential outperformer that is an impressive choice for growth investors, making it a security that you need to keep on your radar in the near term
Bristol-Myers Inks Another Immuno-Oncology Drug Deal http://www.zacks.com/stock/news/188393/bristol-myers-inks-another-immuno-oncology-drug-deal?cid=CS-ZC-FT-188393 Aug 31, 2015 - Bristol-Myers Squibb Company (BMY) announced that it has entered into a research collaboration and license agreement with QIMR Berghofer Medical Research Institute.
Novartis' Farydak Gets EU Approval for Multiple Myeloma http://www.zacks.com/stock/news/189134/novartis-farydak-gets-eu-approval-for-multiple-myeloma?cid=CS-ZC-FT-189134 Sep 07, 2015 - Novartis' (NVS) Farydak (plus Velcade and dexamethasone) gets EU approval for relapsed and/or refractory multiple myeloma in treatment-experienced patients.
Bristol-Myers' (BMY) Opdivo Gets Priority Review, Shares Up http://www.zacks.com/stock/news/188930/bristol-myers-bmy-opdivo-gets-priority-review-shares-up?cid=CS-ZC-FT-188930 Sep 03, 2015 - Bristol-Myers Squibb Company (BMY) announced that the supplemental Biologics License Application for Opdivo has been accepted with priority review by the FDA.
Perrigo (PRGO) Buys Scar Management Brand from Enaltus http://www.zacks.com/stock/news/188561/perrigo-prgo-buys-scar-management-brand-from-enaltus?cid=CS-ZC-FT-188561 Sep 01, 2015 - Perrigo Company plc (PRGO) announced that it has acquired a leading U.S. OTC scar management brand, ScarAway, from Enaltus.

Pages: 123456...17

Page 1>